These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 12009274)
1. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Welkos S; Pitt ML; Martinez M; Friedlander A; Vogel P; Tammariello R Vaccine; 2002 May; 20(17-18):2206-14. PubMed ID: 12009274 [TBL] [Abstract][Full Text] [Related]
2. Absence of inflammation and pneumonia during infection with nonpigmented Yersinia pestis reveals a new role for the pgm locus in pathogenesis. Lee-Lewis H; Anderson DM Infect Immun; 2010 Jan; 78(1):220-30. PubMed ID: 19841077 [TBL] [Abstract][Full Text] [Related]
3. Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092. Welkos SL; Friedlander AM; Davis KJ Microb Pathog; 1997 Oct; 23(4):211-23. PubMed ID: 9344782 [TBL] [Abstract][Full Text] [Related]
4. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague. Szaba FM; Kummer LW; Wilhelm LB; Lin JS; Parent MA; Montminy-Paquette SW; Lien E; Johnson LL; Smiley ST Infect Immun; 2009 Oct; 77(10):4295-304. PubMed ID: 19620344 [TBL] [Abstract][Full Text] [Related]
5. Deletion of Braun lipoprotein and plasminogen-activating protease-encoding genes attenuates Yersinia pestis in mouse models of bubonic and pneumonic plague. van Lier CJ; Sha J; Kirtley ML; Cao A; Tiner BL; Erova TE; Cong Y; Kozlova EV; Popov VL; Baze WB; Chopra AK Infect Immun; 2014 Jun; 82(6):2485-503. PubMed ID: 24686064 [TBL] [Abstract][Full Text] [Related]
6. Deletion of Braun lipoprotein gene (lpp) and curing of plasmid pPCP1 dramatically alter the virulence of Yersinia pestis CO92 in a mouse model of pneumonic plague. Agar SL; Sha J; Baze WB; Erova TE; Foltz SM; Suarez G; Wang S; Chopra AK Microbiology (Reading); 2009 Oct; 155(Pt 10):3247-3259. PubMed ID: 19589835 [TBL] [Abstract][Full Text] [Related]
7. Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague. Tiner BL; Sha J; Ponnusamy D; Baze WB; Fitts EC; Popov VL; van Lier CJ; Erova TE; Chopra AK Clin Vaccine Immunol; 2015 Dec; 22(12):1255-68. PubMed ID: 26446423 [TBL] [Abstract][Full Text] [Related]
8. Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulence. Eddy JL; Schroeder JA; Zimbler DL; Caulfield AJ; Lathem WW J Thromb Haemost; 2016 Sep; 14(9):1833-43. PubMed ID: 27377187 [TBL] [Abstract][Full Text] [Related]
9. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Sha J; Agar SL; Baze WB; Olano JP; Fadl AA; Erova TE; Wang S; Foltz SM; Suarez G; Motin VL; Chauhan S; Klimpel GR; Peterson JW; Chopra AK Infect Immun; 2008 Apr; 76(4):1390-409. PubMed ID: 18227160 [TBL] [Abstract][Full Text] [Related]
10. Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague. Sun W; Roland KL; Kuang X; Branger CG; Curtiss R Infect Immun; 2010 Mar; 78(3):1304-13. PubMed ID: 20086087 [TBL] [Abstract][Full Text] [Related]
11. Identification of New Virulence Factors and Vaccine Candidates for Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192 [TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Arnaboldi PM; Sambir M; D'Arco C; Peters LA; Seegers JF; Mayer L; McCormick AA; Dattwyler RJ Vaccine; 2016 Nov; 34(47):5768-5776. PubMed ID: 27745954 [TBL] [Abstract][Full Text] [Related]
13. Rational considerations about development of live attenuated Yersinia pestis vaccines. Sun W; Curtiss R Curr Pharm Biotechnol; 2013; 14(10):878-86. PubMed ID: 24372254 [TBL] [Abstract][Full Text] [Related]
14. Modification of the Pulmonary MyD88 Inflammatory Response Underlies the Role of the Yersinia pestis Pigmentation Locus in Primary Pneumonic Plague. Olson RM; Dhariwala MO; Mitchell WJ; Skyberg JA; Anderson DM Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33257532 [TBL] [Abstract][Full Text] [Related]
15. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734 [TBL] [Abstract][Full Text] [Related]
16. Characterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain. Mellado-Sanchez G; Ramirez K; Drachenberg CB; Diaz-McNair J; Rodriguez AL; Galen JE; Nataro JP; Pasetti MF Comp Immunol Microbiol Infect Dis; 2013 Mar; 36(2):113-28. PubMed ID: 23195858 [TBL] [Abstract][Full Text] [Related]
17. Immunity in plague: protection of the vervet (Cercopithecus aethips) against pneumonic plague by the oral administration of live attenuated Yersinia pestis. Chen TH; Elberg SS; Eisler DM J Infect Dis; 1977 Feb; 135(2):289-93. PubMed ID: 402428 [TBL] [Abstract][Full Text] [Related]